96 related articles for article (PubMed ID: 3087831)
21. Subacute myelogenous leukemia. A special type of myelogenous leukemia.
Yang CL; Yang WW; Qi SL; Yang TY; Wang YL
Chin Med J (Engl); 1982 Jun; 95(6):459-66. PubMed ID: 6813055
[No Abstract] [Full Text] [Related]
22. [Megakaryocytic variant of myelocytic leukemia].
Kuraleva VV; Freĭdzon VA; Teodorovich VI
Lab Delo; 1977; (2):76-8. PubMed ID: 68146
[No Abstract] [Full Text] [Related]
23. [Histological variants of chronic myeloleukemia and their clinical significance].
Semenova EA; Khokhlova MP; Khoroshko ND; Nevskaia TP; Turkina AG
Gematol Transfuziol; 1988 Mar; 33(3):24-8. PubMed ID: 3164285
[No Abstract] [Full Text] [Related]
24. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS
Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107
[TBL] [Abstract][Full Text] [Related]
25. The value of bone marrow biopsy in chronic myeloid leukaemia.
Seewann HL; Lehnert M; Jüttner F
Haematologia (Budap); 1983; 16(1-4):67-72. PubMed ID: 6592124
[TBL] [Abstract][Full Text] [Related]
26. Extramedullary myeloblastic transformation of chronic myelocytic leukemia. Lymph node infiltration one year before marrow blastic change.
Woodson DL; Bennett DE; Sears DA
Arch Intern Med; 1974 Sep; 134(3):523-6. PubMed ID: 4527801
[No Abstract] [Full Text] [Related]
27. Classification of the myelodysplastic syndromes.
Bennett JM
Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
[No Abstract] [Full Text] [Related]
28. [Clinicopathologic conference. The so-called acceleration phase of chronic myeloid leukemia (CML)].
Zankovich R; Thiele J; Fischer R; Diehl V
Med Klin (Munich); 1986 Apr; 81(7):245-50. PubMed ID: 3466004
[No Abstract] [Full Text] [Related]
29. Prognostic features at diagnosis of chronic myeloid leukaemia with special emphasis on histological parameters.
Thiele J; Thienel C; Zankovich R; Fischer R
Med Oncol Tumor Pharmacother; 1988; 5(1):49-60. PubMed ID: 3163405
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of bone marrow biopsy in essential thrombocythemia.
Annaloro C; Lambertenghi Deliliers G; Oriani A; Pozzoli E; Lambertenghi Deliliers D; Radaelli F; Faccini P
Haematologica; 1999 Jan; 84(1):17-21. PubMed ID: 10091388
[TBL] [Abstract][Full Text] [Related]
31. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
Seewann HL
Wien Med Wochenschr Suppl; 1986; 100():1-24. PubMed ID: 3471009
[TBL] [Abstract][Full Text] [Related]
32. [Study of granulocyte-monocyte stem cells (CFU-GM) in vitro from peripheral blood and bone marrow in various phases of chronic myeloid leukemia].
Florensa L; Woessner S; Lafuente R; Sans-Sabrafen J
Sangre (Barc); 1985; 30(4-A):397-405. PubMed ID: 3865430
[No Abstract] [Full Text] [Related]
33. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
34. [A cytogenetical study of chronic myeloid leukemia, osteomyelosclerosis, myelofibrosis and erythrema].
Piatkin EK
Tsitologiia; 1966; 8(2):229-40. PubMed ID: 5234136
[No Abstract] [Full Text] [Related]
35. Thrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic myeloproliferative disorders.
Douglas VK; Tallman MS; Cripe LD; Peterson LC
Am J Clin Pathol; 2002 Jun; 117(6):844-50. PubMed ID: 12047134
[TBL] [Abstract][Full Text] [Related]
36. [A case of chronic myelogenous leukemia who survived for more than 3 years after sequential lymphoid and myeloid crises and pre-B cell CNS involvement].
Shimizu S; Okamoto M; Ono Y; Hirano M
Rinsho Ketsueki; 1986 Oct; 27(10):1869-73. PubMed ID: 3469426
[No Abstract] [Full Text] [Related]
37. Bone marrow biopsy in clinical medicine: an overview.
Frisch B; Bartl R; Burkhardt R
Haematologia (Budap); 1982; 15(3):245-85. PubMed ID: 6764442
[TBL] [Abstract][Full Text] [Related]
38. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
39. [Chronic myelogenous leukemia with erythrophagocytosis-positive atypical cells in the bone marrow in the terminal phase].
Mohri H; Hagiwara S; Mori H; Matsuno K; Niikura H; Terada H
Rinsho Ketsueki; 1983 Nov; 24(11):1490-4. PubMed ID: 6584650
[No Abstract] [Full Text] [Related]
40. [Significance of histologic bone marrow evaluation in diagnosis of chronic granulocytic leukemia. II. Megakaryocytes].
Komarnicki M; Rasińska M; Woźny T
Acta Haematol Pol; 1995; 26(2):195-200. PubMed ID: 7653225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
